May 20 (Reuters) - European Medicines Agency:
* EMA: EMA STARTED EVALUATING THE USE OF A BOOSTER DOSE OF NOVAVAX'S COVID-19 VACCINE, NUVAXOVID, IN ADULTS: 20/05/2022 Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.78 USD | -1.44% | -1.04% | -0.42% |
Mar. 26 | Novavax Reports Settlement Agreement With Fujifilm | MT |
Mar. 20 | Wall St ends higher as Fed sees three rate cuts | RE |
May 20 (Reuters) - European Medicines Agency:
* EMA: EMA STARTED EVALUATING THE USE OF A BOOSTER DOSE OF NOVAVAX'S COVID-19 VACCINE, NUVAXOVID, IN ADULTS: 20/05/2022 Further company coverage:
1st Jan change | Capi. | |
---|---|---|
-0.42% | 679M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |